Roger E. Susi - 21 Dec 2023 Form 4 Insider Report for IRADIMED CORP (IRMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Dec 2023, 17:15:14 UTC
Prior SEC filing
20 Dec 2023
Next SEC filing
27 Dec 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Roger E. Susi

Key filing fact

Roger E. Susi filed Form 4 for IRADIMED CORP (IRMD) on 22 Dec 2023.

Key facts

  • This page summarizes Roger E. Susi's Form 4 filing for IRADIMED CORP (IRMD).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Dec 2023, 17:15.

Change

  • Previous filing in this sequence was filed on 20 Dec 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRMD transaction

Common Stock

Gift

Transaction value
$0
Shares
-300,000
Change %
-13%
Price
$0.000000
Shares after
2,062,500
Date
21 Dec 2023
Ownership
By Matthew Susi 2008 Dynasty Trust
Footnotes
F1
IRMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
172,950
Date
21 Dec 2023
Ownership
By Roger E. Susi Revocable Trust
IRMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,362,500
Date
21 Dec 2023
Ownership
By Phillip Susi 2008 Dynasty Trust
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .